Bezafibrate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01393 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 10 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | hypoalphalipoproteinemia | KG + DL |
| 2 | hyperlipidemia due to hepatic triglyceride lipase deficiency | KG + DL |
| 3 | hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency | KG + DL |
| 4 | cholesterol-ester transfer protein deficiency | KG + DL |
| 5 | homozygous familial hypercholesterolemia | KG + DL |
| 6 | obsolete familial combined hyperlipidemia | KG + DL |
| 7 | familial hypercholesterolemia | KG + DL |
| 8 | hyperlipoproteinemia | KG + DL |
| 9 | obsolete susceptibility to ischemic stroke | KG + DL |
| 10 | amenorrhea (disease) | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.